Leg arteries : MANAGEMENT and STRATEGY

Similar documents
Present & future of below the knee stenting

Tools and options for recanalisation of long-femoro-popliteal segments

Interactive Tool Box for Below The Knee selected by Max Amor & Joseph Azzi.

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

The essentials for BTK procedures: wires, balloons, what else

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

When is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Specificities for infrapopliteal stents

Endovascular Options in Critical Limb Ischemia: Below The Knee Therapies

Recent Advances in Peripheral Salvage

CLI Treatment Using Long and Scoring Balloons

Copyright HMP Communications

Peripheral Arterial Disease: A Practical Approach

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Or is the ivolution stent a better alternative? EVOLUTION 12-month data

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

Current status in BTK interventions

Could a combination of DCB + stent be the answer in complex SFA lesions

Rotarex mechanical debulking: The Leipzig experience in patients

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

Is a Stent or Scaffold Necessary in The SFA?

Initial Clinical Experience with a Novel Dedicated Cobalt Chromium Stent for the Treatment of Below-the-knee Arterial Disease

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Maximizing Outcomes in a complex population with Drug-coated balloon

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

Annals of Vascular Diseases Advance Published Date: June 2, Horie K, et al.

Long-term results with interwoven nitinol stents vs. BMS vs. DCB

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Advanced d Techniques and Tools to Treat Below the Knee CTO

INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY. VascuFlex Peripheral Stent Systems. Self-Expanding Peripheral Nitinol Stents

When Outcomes Matter, Design Matters

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

Calcified lesions optimal treatment

MEET M. Bosiers K. Deloose P. Peeters. SFA stenting in 2009 : The good and the ugly What factors influence patency?

In foot treatment : what not to do? clinical experience. E.Ducasse MD PhD FEVBS Unit of vascular surgery CHU bordeaux

Do we really need a stent in long SFA lesions? No: DEB is the answer

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

Fielder XT: Initial and. Department of Cardiology, Asan Medical Center, Ulsan University of college of medicine

UC SF. Introduction: Retrograde Access. Pedal Access: When to Do It How Does it Fare. Introduction: Retrograde Access. Introduction: Retrograde Access

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

ENDOVASCULAR TREATMENT OF SFA

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

Konstantinos Katsanos, MSc, MD, PhD, EBIR. Consultant Interventional Radiologist Guy's and St.Thomas' Hospitals, NHS Foundation Trust

Disclosures. Iliac Stenting: How could I mess this up? Surgery vs. Stenting: Gold Standard?

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel

Update in femoral angioplasty & stenting PRO

Crossing the Long SFA CTO

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Angioplasty Summit TCTAP Technical Aspects of Overview in CTO-PCI Toyohashi Heart Center Takahiko Suzuki, M.D

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Outcome and Good Indication of Laser Angioplasty

BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort

Vascular V12. Covered Stent. The New Standard of Care

Chronic Total Occlusion (CTO) Technologies

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA

Dierk Scheinert, MD. Department of Angiology University Hospital Leipzig, Germany

BIOFLEX PEACE Registry

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM

SFA lesion treatment: China experience. Wei Liang, MD

Balloon Expandable Covered Stents. Suddenly a Crowded Space

Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Minimizing Burden, the effect of thin strut and low Chronic Outward Force SE stents

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, PA USA

How do I use mechanical debulking for the treatment of arterial occlusions

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Current Status of Endovascular Therapies for Critical Limb Ischemia

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI

Update on the Ranger clinical trial programme

Latest Insights from the LEVANT II study and sub-group analysis

The BATTLE Trial Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA

January 23, Vascular and oncological interventional radiology Paris Descartes University

Use of Laser In BTK Disease (CLI)

Appropriate Device Selection for Endovascular Procedures

Pulsar stent technology

Guidewire Selection. Making the Most Out of My Guidewire: LINC 2016: Leipzig Interventional Course Leipzig, Germany January 26-29, 2016

SMOOTH VASCULAR ACCESS COMPARATIVE BENCH TOP RESULTS

Atherectomy is Still Live and Effective. John R. Laird, MD Professor of Medicine Medical Director of the Vascular Center UC Davis Health System

Evidence-Based Optimal Treatment for SFA Disease

Update on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany

COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions. Dierk Scheinert

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

Endovascular Intervention BtK Intervention in Patients with Chronic Dialysis

Chronic Total Occlusion (CTO) Technologies. Re-open vital channels

Guide Wires design and selection Abbott Vascular. All rights reserved.

Atrium Advanta V12. Balloon Expandable Covered Stents

Endovascular Therapy vs. Open Femoral Endarterectomy Rationale and Design of the Randomized PESTO Trial

Superficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA

Lessons for Successful Subintimal Angioplasty in SFA CTO

Interventional Radiology in Peripheral Vascular Disease: How Far Can We Go? Dr. L. F. CHENG Department of Radiology Princess Margaret Hospital

Transcription:

Leg arteries : MANAGEMENT and STRATEGY Prof E. Ducasse Unit of vascular surgery BORDEAUX ESVB May 14th 2011 BARD Symposium

CLI : definition Fontaine Rutherford ABI Symptoms class category Asymptomatic I 0 0.85-1 none Mild claudication IIa 1 0.5-0.8 walking distance > 200m Moderate claudication IIb 2 0.5-0.8 walking distance = 100-200m Severe claudication IIb 3 0.5-0.8 walking distance <100 Ischemic rest pain III 4 <0.5 rest pain Minor tissue loss IV 5 <0.5 minor tissue loss (ulceration) Major tissue loss IV 6 <0.5 major tissue loss (gangrene)

DIABETES : EPIDEMIOLOGY Population diabétique (en millions) 400 300 200 100 2000 2030 Scénario 1 : constant obesity + 114% Scénario 2 : obesity!! +??? Epidemiology of «DIABESITY» Wild S, Diabetes Care, 2004

OBESITY : EPIDEMIOLOGY! Booming of obesity

OBESITY : EPIDEMIOLOGY! Obesity is equaly dangerous!

EPIDEMIOLOGICAL NIGHTMARE! Diabetes + obesity : evolution in the US Diabetes BOOMING + obesity BOOMING = CLI explosion

HENCE!! To battle! to avoid major amputation! TASC 2 : ENDOVASCULAR USE FOR BTK LESIONS

ENDOVASCULAR BTK! An Upside-down presentation!devices!guide-wires!access

DEVICES! Stents for BTK! DES: ACHILLES study! Cypher Select Plus! versus angioplasty in BTK lesions! 200 patients - primary endpoint : in segment restenosis at 12 months! 99 Pt DES / 101 Pt PTA (bailout for 8 Pt: DES)! 79.2% Pt available for 12 months follow-up! Treated population! Restenosis rate: 18.7% (DES) Vs 45.5% (PTA) ONLY Balloon Expandable Stent Coronary stents short lesions! DES: DESTINY trial! DES (Xience V) Vs Bare Metal Stent (Multi-link Vision)! 12 months patency: 85.2% (DES) Vs 54.4% (BMS)

DEVICES! IMPORTANT TO STENT!Scheinert et al. EuroPCR 2003, N=74 Vs 58! Technical success 79% Vs 95%! Patency @ M12: 53% Vs 84%!Rand et al. CVIR 2005 N! Randomized prospective study N=52! 6 months patency : 83.7% (stent) Vs 61.1% (PTA)! Overall LS: 98% @ M6

Angioplasty what does it means??! Atherosclerotic lesion compression! Atherosclerotic lesion compressed Plaque ruptured = instability

INSTABILITY what does it means??! It means risk of complications Parietal instability Problems!!! Wall support = security

What is the solution?? To maintain the arterial wall = STENT to maintain the lumen = haemorrhage dissection Lumen free of complications Hence : one solution: to stent the highly calcified lesion, the recanalisation and the remaining lesions

DEVICES for BTK! Dedicated stents for BTK lesions!bes good radial force and good visibility!palmaz blue - 0.018 - OTW! Ø 2 2.5 3 3.5 4 4.5 5 mm! L 10,20,30,40 mm!ses less radial force length superior (up to 200 mm) Xpert 4-5-6 mm 20-40 mm Astron Pulsar over the wire! 0.018! Ø 4 5 6 7 mm! L 20,30,40,60,80 mm

DEVICES for BTK! BES!They may brake!

STENTING: OBVIOUSNESS! Stent on balloon! Precise placement! Good visibility! High radial force (calcifications)! Stent self-expanding! Superior flexibility! Crush resistance! Homogenous parietal covering! dedicated! Low profile! Good radial force BES crush Treatment adding a SES

STENTING : OBVIOUSNESSES! BTK arterial mobility evaluation Knee flexion up to 90 TA TPT TA TPT

PERSONAL ATTITUDE! For lesions < 2 cm without residual flow-limiting lesions : PTA alone! After recanalisation with residual lesion " stenting.!! 1/3 proximal (TPT, ostia TAA, TPA and PA) : ONLY SEStent! Distal part of BTK arteries : BEStent

DEVICES : Balloons! Dedicated balloons!0.018 or 0.014 balloon Oversize the lenght of balloon, But NEVER oversize the diameter size!dedicated diameter and length Ultraverse! 0.018 OTW 2 to 6 mm 2 to 100 mm / shaft 100 and 120 cm

DEVICES! Example: Pre-op Dilation BALLOON 2.5x150 Post-op

! Bad example DEVICES

DEVICES! BAD example : restoration TRICKS Reinflation for remaining lesion = longer balloon

GUIDEWIRES! Guidewires antegrade way!0.035 0.032! GuideWire (Terumo) 180cm!0.018! SV Wire (Cordis) 180cm! V-18 ControlWire (BSci) 180cm! Cruiser (Biotronik) 195 cm and 300 cm!0.014! Asahi (Abbott) 180cm / Pilot and Win wires 300 cm! Cruiser (Biotronik) 190 cm : IDEAL : Chromium enriched Nitinol wire! Coating : Proximal " PTFE on stainless steel shaft Distal " hydrophylic coating! Tip stiffness : high flexible flexible medium! Tip shape : straight Angled

GUIDEWIRES SUMMARY! 0.014 are dedicated for navigation!multistenosed lesions!in foot lesions! 0.018 are dedicated for recanalisation!thrombosis and preocclusive lesions

GUIDEWIRE! Cross the lesion with a 0.014 wire

GUIDEWIRES! Cross the lesion with a 0.014

GUIDEWIRE! No pushability for 0.014 balloon

GUIDEWIRE! From 0.014 to 0.018 : increase the pushability

GUIDEWIRE! 0.018 dedicated balloon cross the lesion

! Dilatation 3 mm GUIDEWIRE

GUIDEWIRE! Control remaining lesion

GUIDEWIRE! Calcified lesion! stent (SES)

! Final control GUIDEWIRE

PERSONAL ATTITUDE Antegrade approach! Antegrade approach TRICKS Under general anaesthesia minor amputation in the same time Don t loose the road mapping : less iodic product Surgical approach of SFA direct closure: no haematoma Clampage: injection, reflux! less iodic product Placement of short sheath at puncture site! 6F, 11cm or 4F long sheath

ACCESS FOCUS! In more than 80% of case, when there is only one remaining BTK artery this is the peroneal artery! If antegrade recanalisation impossible: NO HESITATION: PERONEAL PUNCTION

PERONEAL ACCESS

PERONEAL ACCESS

PERONEAL ACCESS

PERONEAL ACCESS! Retrograde access: same technique, same tools

PERONEAL ACCESS! Remaining peroneal artery

PERONEAL ACCESS! Recananlisation antegrade impossible

PERONEAL ACCESS! Peroneal retrograde punction

PERONEAL ACCESS! 0.018 guidewire recanalisation TPT

CONCLUSION 1! With a good technique and dedicated material:!large and dedicated stenting!dedicated balloon!adapted guide wire!no fear for exotic access! nothing impossible

CONCLUSION 2! Most advanced endovascular treatment for BTK lesions is efficient BEFORE AFTER Thank you